Perspective Therapeutics Inc (CATX) PT Lowered to $7 at UBS: Several Catalysts in 2026
Tweet Send to a Friend
UBS analyst David Dai lowered the price target on Perspective Therapeutics Inc (NYSE: CATX) to $7.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
